Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16707593rdf:typepubmed:Citationlld:pubmed
pubmed-article:16707593lifeskim:mentionsumls-concept:C1551338lld:lifeskim
pubmed-article:16707593lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:16707593lifeskim:mentionsumls-concept:C0023485lld:lifeskim
pubmed-article:16707593lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:16707593lifeskim:mentionsumls-concept:C0205430lld:lifeskim
pubmed-article:16707593lifeskim:mentionsumls-concept:C1881379lld:lifeskim
pubmed-article:16707593pubmed:issue10lld:pubmed
pubmed-article:16707593pubmed:dateCreated2006-5-18lld:pubmed
pubmed-article:16707593pubmed:abstractTextMixed lineage leukemia (MLL) abnormalities occur in approximately 50% of childhood pro-B acute lymphoblastic leukemia (ALL). However, the incidence and type of MLL rearrangements have not been determined in common ALL (cALL) and CD10+ or CD10- pre-B ALL.lld:pubmed
pubmed-article:16707593pubmed:languageenglld:pubmed
pubmed-article:16707593pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16707593pubmed:citationSubsetIMlld:pubmed
pubmed-article:16707593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16707593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16707593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16707593pubmed:statusMEDLINElld:pubmed
pubmed-article:16707593pubmed:monthMaylld:pubmed
pubmed-article:16707593pubmed:issn1078-0432lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:MannGeorgGlld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:HaasOskar AOAlld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:DworzakMichae...lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:GadnerHelmutHlld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:KönigMargitMlld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:MarschalekRol...lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:StrehlSabineSlld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:BorkhardtArnd...lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:AttarbaschiAn...lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:LionThomasTlld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:PicklWinfried...lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:SteinerManuel...lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:MeyerClausClld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:SchneiderBjör...lld:pubmed
pubmed-article:16707593pubmed:authorpubmed-author:Schreiberhube...lld:pubmed
pubmed-article:16707593pubmed:issnTypePrintlld:pubmed
pubmed-article:16707593pubmed:day15lld:pubmed
pubmed-article:16707593pubmed:volume12lld:pubmed
pubmed-article:16707593pubmed:ownerNLMlld:pubmed
pubmed-article:16707593pubmed:authorsCompleteYlld:pubmed
pubmed-article:16707593pubmed:pagination2988-94lld:pubmed
pubmed-article:16707593pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:meshHeadingpubmed-meshheading:16707593...lld:pubmed
pubmed-article:16707593pubmed:year2006lld:pubmed
pubmed-article:16707593pubmed:articleTitleMixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.lld:pubmed
pubmed-article:16707593pubmed:affiliationDepartment of Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria.lld:pubmed
pubmed-article:16707593pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16707593pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed